These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 2966586)

  • 1. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
    Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM
    Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
    Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA
    Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
    Ehrlich CE; Young PC; Cleary RE
    Am J Obstet Gynecol; 1981 Nov; 141(5):539-46. PubMed ID: 6457531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features associated with survival and disease-free survival in early endometrial cancer.
    Sutton GP; Geisler HE; Stehman FB; Young PC; Kimes TM; Ehrlich CE
    Am J Obstet Gynecol; 1989 Jun; 160(6):1385-91; discussion 1391-3. PubMed ID: 2735364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone receptor status in human endometrial adenocarcinoma.
    De Cicco Nardone F; Benedetto MT; Rossiello F; Bongiorno M; Iacobelli S; Mancuso S; Dell'Acqua S
    Cancer; 1989 Dec; 64(12):2572-8. PubMed ID: 2819666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.
    Carlson JA; Allegra JC; Day TG; Wittliff JL
    Am J Obstet Gynecol; 1984 May; 149(2):149-53. PubMed ID: 6232850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma.
    Creasman WT; Soper JT; McCarty KS; McCarty KS; Hinshaw W; Clarke-Pearson DL
    Am J Obstet Gynecol; 1985 Apr; 151(7):922-32. PubMed ID: 3985057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution and prognostic implications of steroid receptors in endometrial carcinomas.
    Utaaker E; Iversen OE; Skaarland E
    Gynecol Oncol; 1987 Sep; 28(1):89-100. PubMed ID: 3653774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
    McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
    Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic importance of steroid receptors in endometrial carcinoma.
    Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.
    Quinn MA; Cauchi M; Fortune D
    Gynecol Oncol; 1985 Jul; 21(3):314-9. PubMed ID: 3159630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma.
    Creasman WT; McCarty KS; Barton TK; McCarty KS
    Obstet Gynecol; 1980 Mar; 55(3):363-70. PubMed ID: 7189047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid hormone receptor content and lymph node status in endometrial cancer.
    Morris PC; Anderson JR; Anderson B; Buller RE
    Gynecol Oncol; 1995 Mar; 56(3):406-11. PubMed ID: 7705676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
    Friedl A; Gottardis MM; Pink J; Buchler DA; Jordan VC
    Cancer Res; 1989 Sep; 49(17):4758-64. PubMed ID: 2758409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance.
    Kleine W; Maier T; Geyer H; Pfleiderer A
    Gynecol Oncol; 1990 Jul; 38(1):59-65. PubMed ID: 2141316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and progesterone receptors in uterine sarcomas.
    Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
    Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of "nuclear" estrogen receptor content on prognosis of early stage carcinoma of the uterine body. A short-time follow-up.
    Horvath G; Johnsson JE; Tropé C; Samuelsson L; Alm P; Olsson H
    Neoplasma; 1990; 37(1):43-6. PubMed ID: 2320180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estrogen and progesterone receptors in corpus uteri carcinoma and their clinical significance].
    Kleine W; Fuchs A; deGregorio G; Geyer H
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):884-7. PubMed ID: 6925560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.